GRAY MARY ANN 1261974 Data last updated 2024-05-14 07:02:16 -0500 US CDT

Latest Holdings

Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.


Non-derivative Transactions     CSV download

Tips: type "code_s" to show transactions with code "S".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-05-15 2023-03-31 2023-03-31 4 Gray Mary Ann DIRECTOR acq 5503.0 30.9 1.15 0.0 Direct Common Stock BIOATLA, INC.

code_A

code  A
17810.0 47.67 (BCAB)
2023-07-05 2023-06-30 2023-06-30 4 Gray Mary Ann DIRECTOR acq 4916.0 21.63 1.03 0.0 Direct Common Stock BIOATLA, INC.

code_A

code  A
22726.0 47.67 (BCAB)
2023-10-03 2023-09-30 2023-09-30 4 Gray Mary Ann DIRECTOR acq 8676.0 27.63 1.81 0.0 Direct Common Stock BIOATLA, INC.

code_A

code  A
31402.0 47.8 (BCAB)
2024-01-03 2023-12-31 2023-12-31 4 Gray Mary Ann DIRECTOR acq 5995.0 16.03 1.25 0.0 Direct Common Stock BIOATLA, INC.

code_A

code  A
37397.0 47.94 (BCAB)

Derivative Transactions

Tips: type "code_m" to show transactions with code "M".

Filing Date Transaction Date Operation Date Original Filing Reporter Relation Opr Amounta %(Owned)b ‱(SO)c Avg Prcd Account Type Full Name Code Remain Shares Outstanding (Million)e
2023-05-25 2023-05-24 2023-05-24 4 Gray Mary Ann DIRECTOR acq 12940.0 100.0 3.77 20.93 Direct Stock Option (Right To Buy) RAPT THERAPEUTICS, INC.

code_A

code  A
12940.0 34.35 (RAPT)
2023-06-08 2023-06-06 2023-06-06 4 Gray Mary Ann DIRECTOR acq 10000.0 100.0 3.38 48.79 Direct Stock Option (Right To Buy) KEROS THERAPEUTICS, INC.

code_A

code  A
10000.0 29.58 (KROS)
2023-06-13 2023-06-11 2023-06-11 4 Gray Mary Ann DIRECTOR acq 5100.0 100.0 7.62 0.0 Direct Restricted Stock Units PALISADE BIO, INC.

code_A

code  A
5100.0 6.7 (PALI)
2023-06-13 2023-06-11 2023-06-11 4 Gray Mary Ann DIRECTOR acq 12160.0 100.0 18.16 1.6 Direct Common Stock Options PALISADE BIO, INC.

code_A

code  A
12160.0 6.7 (PALI)
2023-06-15 2023-06-14 2023-06-14 4 Gray Mary Ann DIRECTOR acq 50000.0 100.0 10.49 3.55 Direct Stock Option (Right To Buy) BIOATLA, INC.

code_A

code  A
50000.0 47.67 (BCAB)
2023-11-24 2023-11-21 2023-11-21 4 Gray Mary Ann DIRECTOR acq 5820.0 100.0 6.31 0.0 Direct Restricted Stock Units PALISADE BIO, INC.

code_A

code  A
5820.0 9.22 (PALI)
2023-11-24 2023-11-21 2023-11-21 4 Gray Mary Ann DIRECTOR acq 6880.0 100.0 7.46 0.59 Direct Common Stock Options PALISADE BIO, INC.

code_A

code  A
6880.0 9.22 (PALI)
2024-02-14 2024-02-09 2024-02-09 4 Gray Mary Ann DIRECTOR acq 40000.0 100.0 3.14 1.57 Direct Stock Option (Right To Buy) COMPASS THERAPEUTICS, INC.

code_A

code  A
40000.0 127.49 (CMPX)
2024-04-01 2024-03-28 2024-03-28 4 Gray Mary Ann DIRECTOR acq 8574.0 100.0 2.49 8.98 Direct Stock Option (Right To Buy) RAPT THERAPEUTICS, INC.

code_A

code  A
8574.0 34.4 (RAPT)

a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)